Concepedia

Eddie Yang

EY

Statistics

Publications

7

Citations

178

H-Index

7

Active since

2012

Affiliations

Pfizer (United States)(Current)

Eddie Yang is an author at Pfizer (United States) specializing in medicinal chemistry, drug discovery, and drug design.

Publications per year

2012–2025

7

Publications

7

Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1

John M. Humphrey, Eddie Yang, Christopher W. am Ende et al. · MedChemComm · 2014 · 37 citations

, , +10

Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability

Martin Pettersson, Douglas S. Johnson, John M. Humphrey et al. · ACS Medicinal Chemistry Letters · 2015 · 33 citations · Full text

, , +17

Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1

John M. Humphrey, Matthew A. Movsesian, Christopher W. am Ende et al. · Journal of Medicinal Chemistry · 2018 · 28 citations · Full text

, , +9

Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease

Jamison B. Tuttle, Christophe Allais, Charlotte Allerton et al. · Journal of Medicinal Chemistry · 2025 · 23 citations

, , +15

Synthesis of α,α-Difluoroethyl Aryl and Heteroaryl Ethers

Eddie Yang, Matthew R. Reese, John M. Humphrey · Organic Letters · 2012 · 22 citations

, , +11

1–5 of 7